Covered recipient · General Payments record
NOUSHIN A FIROUZBAKHT
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$6,927.36
- Reported across 155 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $3,000.00 | 7 |
| Food and Beverage | $476.71 | 24 |
| Education | $99.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| MIMEDX Group, Inc. | $3,000.00 | 7 |
| Biogen, Inc. | $156.97 | 13 |
| SHIELD THERAPEUTICS INC | $149.78 | 4 |
| Astellas Pharma US Inc | $135.83 | 3 |
| VERTEX PHARMACEUTICALS INCORPORATED | $30.88 | 1 |
| Exact Sciences Corporation | $27.82 | 1 |
| MAYNE PHARMA COMMERCIAL LLC | $26.80 | 1 |
| Minerva Surgical, Inc | $24.19 | 1 |
| MILLICENT US INC | $23.44 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (32)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $16.95 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139319334 | CMS |
| Astellas Pharma US Inc | $19.88 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139367171 | CMS |
| Astellas Pharma US Inc | $99.00 | 10/15/2024 | Education | Undisputed | 01/23/2026 | 1139419595 | CMS |
| Biogen, Inc. | $6.62 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104870110 | CMS |
| Biogen, Inc. | $19.01 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104874360 | CMS |
| Biogen, Inc. | $10.55 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104844942 | CMS |
| Biogen, Inc. | $12.33 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104812913 | CMS |
| Biogen, Inc. | $13.86 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104857152 | CMS |
| Biogen, Inc. | $17.63 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104843488 | CMS |
| Biogen, Inc. | $14.73 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104833931 | CMS |
| Biogen, Inc. | $9.74 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104872354 | CMS |
| Biogen, Inc. | $6.00 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104871218 | CMS |
| Biogen, Inc. | $12.72 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104825194 | CMS |
| Biogen, Inc. | $10.60 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104859752 | CMS |
| Biogen, Inc. | $10.00 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104876918 | CMS |
| Biogen, Inc. | $13.18 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104846896 | CMS |
| Exact Sciences Corporation | $27.82 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114657816 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $26.80 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154692075 | CMS |
| MILLICENT US INC | $23.44 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150906912 | CMS |
| MIMEDX Group, Inc. | $200.00 | 04/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1140259109 | CMS |
| MIMEDX Group, Inc. | $600.00 | 05/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1140259111 | CMS |
| MIMEDX Group, Inc. | $1,200.00 | 06/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1140259113 | CMS |
| MIMEDX Group, Inc. | $200.00 | 07/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1140259115 | CMS |
| MIMEDX Group, Inc. | $200.00 | 10/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1140259117 | CMS |
| MIMEDX Group, Inc. | $200.00 | 11/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1140259119 | CMS |
| MIMEDX Group, Inc. | $400.00 | 12/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1140259121 | CMS |
| Minerva Surgical, Inc | $24.19 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1085613135 | CMS |
| SHIELD THERAPEUTICS INC | $22.27 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150118007 | CMS |
| SHIELD THERAPEUTICS INC | $20.28 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150127181 | CMS |
| SHIELD THERAPEUTICS INC | $20.63 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150133331 | CMS |
| SHIELD THERAPEUTICS INC | $86.60 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150155378 | CMS |
| VERTEX PHARMACEUTICALS INCORPORATED | $30.88 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105920651 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.